Al entrar a un enlace saldrá de esta página, luego puede regresar manualmente a esta página
Epidemiología
- WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access
- Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
- A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
- Coronavirus envelope protein: current knowledge
- Inmunidad de grupo (inmunidad de rebaño) y COVID-19
- MMR Vaccine Could Protect Against the Worst Symptoms of COVID-19
- Development and Licensure of Vaccines to Prevent COVID-19 Guidance for Industry
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
- La OMS y UNICEF advierten de un descenso en las vacunaciones durante la COVID-19
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- Sobre la vacuna Sputnik V de Rusia: mejor menos ruido y más datos. Boletín #19
- VACUNACIÓN ANTIGRIPAL 2020-21: RECOMENDACIONES DEL CAV-AEP
- COVID-19 and mRNA Vaccines—First Large Test for a New Approach
- SARS-CoV-2 vaccines in development
- Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
- Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
- Why decoding the immune response to COVID matters for vaccines
- All eyes on a hurdle race for a SARS-CoV-2 vaccine
- Información para entender cómo actúan las vacunas contra el COVID-19
- Vacunas contra el coronavirus: las fortalezas y debilidades de las nueve candidatas más adelantada
- The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
- Información para entender cómo actúan las vacunas de ARNm contra el COVID-19
- Datos acerca de las vacunas contra el COVID-19
- Beneficios de vacunarse contra el COVID-19
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
- Oxford–AstraZeneca COVID-19 vaccine efficacy
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- Ensuring the Safety of COVID-19 Vaccines in the United States
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
- Finding Credible Vaccine Information
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world
- Vacunas contra el coronavirus. Preguntas y respuestas.
- Vacunas ARN y vacunas convencionales
- Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults
- Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines
- Información para entender cómo actúan las vacunas de ARNm contra el COVID-19
- ¿Se debe administrar la vacuna frente a COVID-19 a pacientes anticoagulados o con trastornos de la coagulación?
- Guía para el desarrollo de un plan nacional de despliegue y vacunación para vacunas contra la COVID-19
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
- ESMO STATEMENTS FOR VACCINATION AGAINST COVID-19 IN PATIENTS WITH CANCER
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- Finding Credible Vaccine Information
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world
- Vacunas contra el coronavirus. Preguntas y respuestas.
- Vacunas ARN y vacunas convencionales
- Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults
- Ampliación del informe técnico sobre la autorización de uso de VacunaGam-COVID-Vac (Sputnik V)
- Ampliación del Informe técnico de perfil regulatorio sobre autorización de uso de vacuna Sputnik V en el marco de la Ley 27.573.
- Información acerca de la vacuna contra el COVID-19 de Moderna
- Vacunas contra COVID-19: cinco interrogantes inmunológicos
- Draft landscape and tracker of COVID-19 candidate vaccines
- Covid-19: Israel sees new infections plummet following vaccinations
- Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca
- COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020
- Garantizar la seguridad de las vacunas contra el COVID-19 en los EE. UU.
- Guía para establecer una strategia de comunicación de riesgos sobre vacunas anti COVID-19 OPS
- Coronavirus (COVID-19) Vaccinations Update
- Tablero de información sobre el mercado de la vacuna contra la COVID-19
- COVAXINTM – India’s First Indigenous COVID-19 Vaccine
- RESTRICTED USE OF COVAXIN UNDER CLINICAL TRIAL MODE
- ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) COVISHIELD
- Serum institute in India
- CÓMO SEGUIR LA EVOLUCIÓN DE LOS AVANCES EN EL DESARROLLO DE VACUNAS FRENTE AL COVID-19
- Vacunas contra la COVID-19
- COVID-19 Vaccine Introduction Readiness Tool (VIRAT) Dashboard
- Covid19 visualizer (casos, vacunados)
- Introducción de la vacuna contra la COVID-19: Orientaciones para determinar los grupos prioritarios y elaborar la microplanificación. 18 de enero del 2021
- Informes de seguridad en vacunas
- Seguimiento de vacunas covid19 por país en el mundo
- MMWR Weekly COVID-19 Briefing
- Air Cleaners, HVAC Filters, and Coronavirus (COVID-19)
- Indoor Air in Homes and Coronavirus (COVID-19)
- Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities — Salt Lake City, Utah, April–July 2020
- Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020
- Aerosol and Surface Transmission Potential of SARS-CoV-2
- Temporal dynamics in viral shedding and transmissibility of COVID-19
- COVID-19 Might Be Most Transmissible in the Presymptomatic Period
- Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal–Oral Transmission? A COVID-19 Virological and Clinical Review
- COVID-19: in the footsteps of Ernest Shackleton
- How can airborne transmission of COVID-19 indoors be minimised?
- The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission
- Inmunidad de grupo (inmunidad de rebaño) y COVID-19
- How COVID-19 Spreads
- Cómo se propaga el COVID-19
- Criteria for releasing COVID-19 patients from isolation
- Pets and Other Animals
- Si tiene mascotas
- Transplacental transmission of SARS-CoV-2 infection
- COVID-19 zugzwang: Potential public health moves towards population (herd) immunity
- Transmission of SARS-CoV-2: implications for infection prevention precautions
- Absence of Apparent Transmission of SARS-CoV-2 from Two Stylists After Exposure at a Hair Salon with a Universal Face Covering Policy — Springfield, Missouri, May 2020
- Duration of Isolation and Precautions for Adults with COVID-19
- https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions
- Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)
- A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples
- A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19
- Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic
- Seroprevalence and presentation of SARS-CoV-2 in pregnancy
- Policy Review: Evidence and Considerations for School Reopenings
- Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine
- Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
- Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention
- Mapa de movilidad de las personas
- Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection
- Factors Influencing Risk for COVID-19 Exposure Among Young Adults Aged 18–23 Years — Winnebago County, Wisconsin, March–July 2020
- Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities — Salt Lake City, Utah, April–July 2020
- Preventing COVID-19 Outbreaks in Long-Term Care Facilities Through Preemptive Testing of Residents and Staff Members — Fulton County, Georgia, March–May 2020
- Genomic evidence for reinfection with SARS-CoV-2: a case study
- COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020
- Multiple COVID-19 Outbreaks Linked to a Wedding Reception in Rural Maine — August 7–September 14, 2020
- Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China
- Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years — Mississippi, September–November 2020
- SARS-CoV-2 Spike Mutant Protein
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- Evolution of antibody immunity to SARS-CoV-2
- COVAX Statement on New Variants of SARS-CoV-2
- The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children
- Ampliación del informe técnico sobre la autorización de uso de VacunaGam-COVID-Vac (Sputnik V)
- Ampliación del Informe técnico de perfil regulatorio sobre autorización de uso de vacuna Sputnik V en el marco de la Ley 27.573.
- Información acerca de la vacuna contra el COVID-19 de Moderna
- Vacunas contra COVID-19: cinco interrogantes inmunológicos
- Draft landscape and tracker of COVID-19 candidate vaccines
- Covid-19: Israel sees new infections plummet following vaccinations
- COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020
- Coronavirus (COVID-19) Vaccinations Update
- Tablero de información sobre el mercado de la vacuna contra la COVID-19
- COVAXINTM – India’s First Indigenous COVID-19 Vaccine
- RESTRICTED USE OF COVAXIN UNDER CLINICAL TRIAL MODE
- ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) COVISHIELD
- Serum institute in India
- CÓMO SEGUIR LA EVOLUCIÓN DE LOS AVANCES EN EL DESARROLLO DE VACUNAS FRENTE AL COVID-19
- Vacunas contra la COVID-19
- COVID-19 Vaccine Introduction Readiness Tool (VIRAT) Dashboard
- Covid19 visualizer (casos, vacunados)
- Acerca de las variantes del virus que causa el COVID-19
- Clusters of SARS-CoV-2 Infection Among Elementary School Educators and Students in One School District — Georgia, December 2020–January 2021
- Por qué es importante el desglose de datos durante una pandemia – OPS
- Covid-19, el caso Nicaragua. Aportes para enfrentar la pandemia. ACN
- Mapa de movilidad de las personas
- CORONAVIRUS: LA SALUD GLOBAL EN ELPUNTODE MIRA. National Geographic
- Report 12 – The global impact of COVID-19 and strategies for mitigation and suppression
- Centroamérica y su lucha por “aplanar la curva” del SARS-CoV-2 (Parte 1)
- Encuesta de Conocimientos, Actitudes y Prácticas frente a COVID-19
- Symptom clusters in Covid19: A potential clinical prediction tool from the COVID Symptom study app
- A pandemic primer on excess mortality statistics and their comparability across countries
- Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
- Tracking covid-19 excess deaths across countries
- Wrong but Useful — What Covid-19 Epidemiologic Models Can and Cannot Tell Us
- COVID-19 Scenario Analysis Tool
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
- FUNIDES Informe de coyuntura
- Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
- Informes de Movilidad Local
- EuroMOMO is a European mortality monitoring activity, aiming to detect and measure excess deaths related to seasonal influenza, pandemics and other public health threats.
- Covid Performance Index
- COVID-19 Projections Nicaragua
